ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Valerio Therapeutics

Valerio Therapeutics (ALVIO)

0,1954
0,0038
(1,98%)
Geschlossen 06 Juni 5:30PM

Valerio Therapeutics (ALVIO) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,1954
( 1,98% )
Gebot
0,19
Fragen
0,1954
Volumen
196.587
0,1854 Tagesbereich 0,1954
0,0422 52-Wochen-Bereich 0,31
Marktkapitalisierung
Handelsende
0,1916
Handelsbeginn
0,1916
Letzte Trade
50
@
0.1954
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
294.579 €
Ausgegebene Aktien
499.448.301
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-9,29
Gewinn pro Aktie (EPS)
-0,02
Erlöse (LTM)
2,57M
Nettogewinn (LTM)
-4,9M

Über Valerio Therapeutics

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product po... Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies. The company develops PlatON, a proprietary chemical platform for DNA decoy therapies, which generates new compounds and broadens its product portfolio; DecoyTAC, a mechanism of action of DNA decoy therapies coupled with targeted protein degradation; and V-body platform, a bispecific T-cell engagers, antibody– drug conjugates, and chimeric antigen receptors. The company was formerly known as Onxeo SA and changed its name to Valerio Therapeutics Société anonyme in June 2023. Valerio Therapeutics Société anonyme was incorporated in 1997 and is headquartered in Paris, France. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Paris, France
Gegründet
1997
Valerio Therapeutics is listed in the Healthcare sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0,19 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0,0422 € to 0,31 €.

Valerio Therapeutics currently has 499.448.301 shares in issue. The market capitalisation of Valerio Therapeutics is 97,59 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.29.

ALVIO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0002-0.1022494887530.19560.19560.18542076920.19127259DE
40.027416.30952380950.1680.2260.1564694480.18380014DE
120.060945.27881040890.13450.2260.10253326870.16149471DE
260.024914.60410557180.17050.2260.10253084880.15262062DE
520.1316206.2695924760.06380.310.04225685330.15885815DE
156-0.0776-28.42490842490.2730.3480.04012572320.14551385DE
260-0.0776-28.42490842490.2730.3480.04012572320.14551385DE

ALVIO - Frequently Asked Questions (FAQ)

What is the current Valerio Therapeutics share price?
The current share price of Valerio Therapeutics is 0,1954 €
How many Valerio Therapeutics shares are in issue?
Valerio Therapeutics has 499.448.301 shares in issue
What is the market cap of Valerio Therapeutics?
The market capitalisation of Valerio Therapeutics is EUR 97,59M
What is the 1 year trading range for Valerio Therapeutics share price?
Valerio Therapeutics has traded in the range of 0,0422 € to 0,31 € during the past year
What is the PE ratio of Valerio Therapeutics?
The price to earnings ratio of Valerio Therapeutics is -9,29
What is the cash to sales ratio of Valerio Therapeutics?
The cash to sales ratio of Valerio Therapeutics is 36,07
What is the registered address of Valerio Therapeutics?
The registered address for Valerio Therapeutics is 49, boulevard du GEnEral Martial Valin, Paris, Ile-de-France, 75015
What is the Valerio Therapeutics website address?
The website address for Valerio Therapeutics is valeriotx.com
Which industry sector does Valerio Therapeutics operate in?
Valerio Therapeutics operates in the Biotechnology & Life Sciences sector

ALVIO Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen